Newsletter
A Growth Mindset for Orthopedic Care

Day Zero

A Growth Mindset for Orthopedic Care

In this episode, Dr. Rishi Sikka, venture partner at Lifeforce Capital and Professor of the Practice of Health Services, Policy and Practice at Brown University School of Public Health, speaks…
October 11, 2022

A Growth Mindset for Orthopedic Care

Meet Kian Raiszadeh, M.D.:

Kian Raiszadeh, M.D. is the Founder and CEO of SpineZone, which provides an alternative approach to neck and back pain without the use of surgery or medications. Dr. Raiszadeh is also an Orthopaedic Surgeon at Kaiser Permanente. Dr. Raiszadeh receive his bachelor’s from the University of California, Berkeley and his M.D. from the University of California, San Diego

 

Key Insights:

Kian Raiszadeh, M.D. is an Orthopaedic Surgeon trying to cannibalize his own job.

 

  • Biopsychosocial Model. This model approaches health from an interdisciplinary perspective, analyzing the impact of factors like diet, sleep, exercise, stress, and mental state on a patient’s health and pain.
  • Why Venture Capital? SpineZone transitioned to venture capital funding when they saw an opportunity to scale the business and have more support. A mentor once told Dr. Raiszadeh that what gets you to one accomplishment won’t necessarily get you to the next. 
  • Executing Strategy. For Dr. Raiszadeh, if he’s not spending at least a day or two a week thinking about the next one to two years, then he’s not adequately spending his time. It’s important for founders to be aware of market trends and to routinely evaluate their long-term strategy.

This episode is hosted by Rishi Sikka, M.D. He is a guest host for Day Zero and is a Senior Advisor for McKinsey & Company.

 

Relevant Links:

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
Adopting Clinical Trial Technology: The Key to Success for Patients, Sites, & Researchers Adoption of new clinical trial technologies is critical to success. These innovations can lift patient burden, improve patient engagement, and increase equity and access to clinical trials.